-
1
-
-
77953734857
-
Heat Shock Protein 70 (Hsp70) as an emerging drug target
-
Evans, C. G.; Chang, L.; Gestwicki, J. E. Heat Shock Protein 70 (Hsp70) as an emerging drug target J. Med. Chem. 2010, 53, 4585-4602
-
(2010)
J. Med. Chem.
, vol.53
, pp. 4585-4602
-
-
Evans, C.G.1
Chang, L.2
Gestwicki, J.E.3
-
2
-
-
84865618692
-
Inhibition of HSP70: A challenging anti-cancer strategy
-
Goloudina, A. R.; Demidov, O. N.; Garrido, C. Inhibition of HSP70: A challenging anti-cancer strategy Cancer Lett. 2012, 325, 117-124
-
(2012)
Cancer Lett.
, vol.325
, pp. 117-124
-
-
Goloudina, A.R.1
Demidov, O.N.2
Garrido, C.3
-
3
-
-
77954947810
-
The HSP70 chaperone machinery: J proteins as drivers of functional specificity
-
Kampinga, H. H.; Craig, E. A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity Nat. Rev. Mol. Cell Biol. 2010, 11, 579-592
-
(2010)
Nat. Rev. Mol. Cell Biol.
, vol.11
, pp. 579-592
-
-
Kampinga, H.H.1
Craig, E.A.2
-
4
-
-
34447530408
-
Molecular chaperones regulate p53 and suppress senescence programs
-
Sherman, M.; Gabai, V.; O'Callaghan, C.; Yaglom, J. Molecular chaperones regulate p53 and suppress senescence programs FEBS Lett. 2007, 581, 3711-3715
-
(2007)
FEBS Lett.
, vol.581
, pp. 3711-3715
-
-
Sherman, M.1
Gabai, V.2
O'Callaghan, C.3
Yaglom, J.4
-
5
-
-
18844378888
-
Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents
-
Gabai, V. L.; Budagova, K. R.; Sherman, M. Y. Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents Oncogene 2005, 24, 3328-3338
-
(2005)
Oncogene
, vol.24
, pp. 3328-3338
-
-
Gabai, V.L.1
Budagova, K.R.2
Sherman, M.Y.3
-
6
-
-
21744445069
-
Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications
-
Ciocca, D. R.; Calderwood, S. K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 2005, 10, 86-103
-
(2005)
Cell Stress Chaperones
, vol.10
, pp. 86-103
-
-
Ciocca, D.R.1
Calderwood, S.K.2
-
7
-
-
50349096803
-
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
-
Powers, M. V.; Clarke, P. A.; Workman, P. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis Cancer Cell 2008, 14, 250-262
-
(2008)
Cancer Cell
, vol.14
, pp. 250-262
-
-
Powers, M.V.1
Clarke, P.A.2
Workman, P.3
-
8
-
-
28544433004
-
Abrogation of heat shock protein 70 induction as a strategy, to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin
-
Guo, F.; Rocha, K.; Bali, P.; Pranpat, M.; Fiskus, W.; Boyapalle, S.; Kumaraswamy, S.; Balasis, M.; Greedy, B.; Armitage, E. S. M.; Lawrence, N.; Bhalla, K. Abrogation of heat shock protein 70 induction as a strategy, to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin Cancer Res. 2005, 65, 10536-10544
-
(2005)
Cancer Res.
, vol.65
, pp. 10536-10544
-
-
Guo, F.1
Rocha, K.2
Bali, P.3
Pranpat, M.4
Fiskus, W.5
Boyapalle, S.6
Kumaraswamy, S.7
Balasis, M.8
Greedy, B.9
Armitage, E.S.M.10
Lawrence, N.11
Bhalla, K.12
-
9
-
-
4644234197
-
Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo
-
Grossin, L.; Etienne, S.; Gaborit, N.; Pinzano, A.; Cournil-Henrionnet, C.; Gerard, C.; Payan, E.; Netter, P.; Terlain, B.; Gillet, P. Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo Biorheology 2004, 41, 521-534
-
(2004)
Biorheology
, vol.41
, pp. 521-534
-
-
Grossin, L.1
Etienne, S.2
Gaborit, N.3
Pinzano, A.4
Cournil-Henrionnet, C.5
Gerard, C.6
Payan, E.7
Netter, P.8
Terlain, B.9
Gillet, P.10
-
10
-
-
0031443856
-
Induction of PBP74/mortalin/Grp75, a member of the hsp70 family, by low doses of ionizing radiation: A possible role in induced radioresistance
-
Sadekova, S.; Lehnert, S.; Chow, T. Y. K. Induction of PBP74/mortalin/Grp75, a member of the hsp70 family, by low doses of ionizing radiation: a possible role in induced radioresistance Int. J. Radiat. Biol. 1997, 72, 653-660
-
(1997)
Int. J. Radiat. Biol.
, vol.72
, pp. 653-660
-
-
Sadekova, S.1
Lehnert, S.2
Chow, T.Y.K.3
-
11
-
-
0031842063
-
MKT-077, localized lipophilic cation: Antitumor activity against human tumor xenografts serially transplanted into nude mice
-
Chiba, Y.; Kubota, T.; Watanabe, M.; Matsuzaki, S. W.; Otani, Y.; Teramoto, T.; Matsumoto, Y.; Koya, K.; Kitajima, M. MKT-077, localized lipophilic cation: Antitumor activity against human tumor xenografts serially transplanted into nude mice Anticancer Res. 1998, 18, 1047-1052
-
(1998)
Anticancer Res.
, vol.18
, pp. 1047-1052
-
-
Chiba, Y.1
Kubota, T.2
Watanabe, M.3
Matsuzaki, S.W.4
Otani, Y.5
Teramoto, T.6
Matsumoto, Y.7
Koya, K.8
Kitajima, M.9
-
12
-
-
0030064081
-
MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation
-
Koya, K.; Li, Y.; Wang, H.; Ukai, T.; Tatsuta, N.; Kawakami, M.; Shishido, T.; Chen, L. B. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation Cancer Res. 1996, 56, 538-543
-
(1996)
Cancer Res.
, vol.56
, pp. 538-543
-
-
Koya, K.1
Li, Y.2
Wang, H.3
Ukai, T.4
Tatsuta, N.5
Kawakami, M.6
Shishido, T.7
Chen, L.B.8
-
13
-
-
0034671731
-
Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function
-
Wadhwa, R.; Sugihara, T.; Yoshida, A.; Nomura, H.; Reddel, R. R.; Simpson, R.; Maruta, H.; Kaul, S. C. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function Cancer Res. 2000, 60, 6818-6821
-
(2000)
Cancer Res.
, vol.60
, pp. 6818-6821
-
-
Wadhwa, R.1
Sugihara, T.2
Yoshida, A.3
Nomura, H.4
Reddel, R.R.5
Simpson, R.6
Maruta, H.7
Kaul, S.C.8
-
14
-
-
84872680675
-
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
-
Wang, A. M.; Miyata, Y.; Klinedinst, S.; Peng, H.-M.; Chua, J. P.; Komiyama, T.; Li, X.; Morishima, Y.; Merry, D. E.; Pratt, W. B.; Osawa, Y.; Collins, C. A.; Gestwicki, J. E.; Lieberman, A. P. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation Nat. Chem. Biol. 2013, 9, 112-118
-
(2013)
Nat. Chem. Biol.
, vol.9
, pp. 112-118
-
-
Wang, A.M.1
Miyata, Y.2
Klinedinst, S.3
Peng, H.-M.4
Chua, J.P.5
Komiyama, T.6
Li, X.7
Morishima, Y.8
Merry, D.E.9
Pratt, W.B.10
Osawa, Y.11
Collins, C.A.12
Gestwicki, J.E.13
Lieberman, A.P.14
-
15
-
-
0033942891
-
Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077
-
Tikoo, A.; Shakri, R.; Connolly, L.; Hirokawa, Y.; Shishido, T.; Bowers, B.; Ye, L. H.; Kohama, K.; Simpson, R. J.; Maruta, H. Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077 Cancer J. 2000, 6, 162-168
-
(2000)
Cancer J.
, vol.6
, pp. 162-168
-
-
Tikoo, A.1
Shakri, R.2
Connolly, L.3
Hirokawa, Y.4
Shishido, T.5
Bowers, B.6
Ye, L.H.7
Kohama, K.8
Simpson, R.J.9
Maruta, H.10
-
16
-
-
79960927001
-
Allosteric drugs: The interaction of antitumor compound MKT-077 with human Hsp70 chaperones
-
Rousaki, A.; Miyata, Y.; Jinwal, U. K.; Dickey, C. A.; Gestwicki, J. E.; Zuiderweg, E. R. P. Allosteric drugs: The interaction of antitumor compound MKT-077 with human Hsp70 chaperones J. Mol. Biol. 2011, 411, 614-632
-
(2011)
J. Mol. Biol.
, vol.411
, pp. 614-632
-
-
Rousaki, A.1
Miyata, Y.2
Jinwal, U.K.3
Dickey, C.A.4
Gestwicki, J.E.5
Zuiderweg, E.R.P.6
-
17
-
-
84860369416
-
Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance
-
Koren, J., III; Miyata, Y.; Kiray, J.; O'Leary, J. C., III; Nguyen, L.; Guo, J.; Blair, L. J.; Li, X.; Jinwal, U. K.; Cheng, J. Q.; Gestwicki, J. E.; Dickey, C. A. Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance PLoS One 2012, 7, e35566
-
(2012)
PLoS One
, vol.7
, pp. 35566
-
-
Miyata, Y.1
Kiray, J.2
Nguyen, L.3
Guo, J.4
Blair, L.J.5
Li, X.6
Jinwal, U.K.7
Cheng, J.Q.8
Gestwicki, J.E.9
Dickey, C.A.10
-
18
-
-
0036682377
-
Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo
-
Wadhwa, R.; Colgin, L.; Yaguchi, T.; Taira, K.; Reddel, R. R.; Kaul, S. C. Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo Cancer Res. 2002, 62, 4434-4438
-
(2002)
Cancer Res.
, vol.62
, pp. 4434-4438
-
-
Wadhwa, R.1
Colgin, L.2
Yaguchi, T.3
Taira, K.4
Reddel, R.R.5
Kaul, S.C.6
-
19
-
-
36749002683
-
Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins
-
Didelot, C.; Lanneau, D.; Brunet, M.; Joly, A.-L.; De Thonel, A.; Chiosis, G.; Garrido, C. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins Curr. Med. Chem. 2007, 14, 2839-2847
-
(2007)
Curr. Med. Chem.
, vol.14
, pp. 2839-2847
-
-
Didelot, C.1
Lanneau, D.2
Brunet, M.3
Joly, A.-L.4
De Thonel, A.5
Chiosis, G.6
Garrido, C.7
-
20
-
-
77955661115
-
Hsp90 inhibition: Elimination of shock and stress
-
Duerfeldt, A. S.; Blagg, B. S. J. Hsp90 inhibition: elimination of shock and stress Bioorg. Med. Chem. Lett. 2010, 20, 4983-4987
-
(2010)
Bioorg. Med. Chem. Lett.
, vol.20
, pp. 4983-4987
-
-
Duerfeldt, A.S.1
Blagg, B.S.J.2
-
21
-
-
0032978456
-
Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent
-
Tatsuta, N.; Suzuki, H.; Mochizuki, T.; Koya, K.; Kawakami, M.; Shishido, T.; Motoji, N.; Kuroiwa, H.; Shigematsu, A.; Chen, L. B. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent Cancer Chemother. Pharmacol. 1999, 43, 295-301
-
(1999)
Cancer Chemother. Pharmacol.
, vol.43
, pp. 295-301
-
-
Tatsuta, N.1
Suzuki, H.2
Mochizuki, T.3
Koya, K.4
Kawakami, M.5
Shishido, T.6
Motoji, N.7
Kuroiwa, H.8
Shigematsu, A.9
Chen, L.B.10
-
22
-
-
84879767467
-
Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces Tau levels
-
Miyata, Y.; Li, X.; Lee, H.-F.; Jinwal, U. K.; Srinivasan, S. R.; Seguin, S. P.; Young, Z. T.; Brodsky, J. L.; Dickey, C. A.; Sun, D.; Gestwicki, J. E. Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces Tau levels ACS Chem. Neurosci. 2013, 4, 930-939
-
(2013)
ACS Chem. Neurosci.
, vol.4
, pp. 930-939
-
-
Miyata, Y.1
Li, X.2
Lee, H.-F.3
Jinwal, U.K.4
Srinivasan, S.R.5
Seguin, S.P.6
Young, Z.T.7
Brodsky, J.L.8
Dickey, C.A.9
Sun, D.10
Gestwicki, J.E.11
-
23
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63
-
(1983)
J. Immunol. Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
24
-
-
84875414858
-
A modified HSP70 inhibitor shows broad activity as an anticancer agent
-
Balaburski, G. M.; Leu, J. I. J.; Beeharry, N.; Hayik, S.; Andrake, M. D.; Zhang, G.; Herlyn, M.; Villanueva, J.; Dunbrack, R. L., Jr.; Yen, T.; George, D. L.; Murphy, M. E. A modified HSP70 inhibitor shows broad activity as an anticancer agent Mol. Cancer Res. 2013, 11, 219-229
-
(2013)
Mol. Cancer Res.
, vol.11
, pp. 219-229
-
-
Balaburski, G.M.1
Leu, J.I.J.2
Beeharry, N.3
Hayik, S.4
Andrake, M.D.5
Zhang, G.6
Herlyn, M.7
Villanueva, J.8
Dunbrack Jr., R.L.9
Yen, T.10
George, D.L.11
Murphy, M.E.12
-
25
-
-
66249138886
-
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
-
Caldas-Lopes, E.; Cerchietti, L.; Ahn, J. H.; Clement, C. C.; Robles, A. I.; Rodina, A.; Moulick, K.; Taldone, T.; Gozman, A.; Guo, Y.; Wu, N.; de Stanchina, E.; White, J.; Gross, S. S.; Ma, Y.; Varticovski, L.; Melnick, A.; Chiosis, G. Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 8368-8373
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 8368-8373
-
-
Caldas-Lopes, E.1
Cerchietti, L.2
Ahn, J.H.3
Clement, C.C.4
Robles, A.I.5
Rodina, A.6
Moulick, K.7
Taldone, T.8
Gozman, A.9
Guo, Y.10
Wu, N.11
De Stanchina, E.12
White, J.13
Gross, S.S.14
Ma, Y.15
Varticovski, L.16
Melnick, A.17
Chiosis, G.18
-
26
-
-
33746714410
-
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines
-
Wasielewski, M.; Elstrodt, F.; Klijn, J. G. M.; Berns, E. M. J. J.; Schutte, M. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines Breast Cancer Res. Treat. 2006, 99, 97-101
-
(2006)
Breast Cancer Res. Treat.
, vol.99
, pp. 97-101
-
-
Wasielewski, M.1
Elstrodt, F.2
Klijn, J.G.M.3
Berns, E.M.J.J.4
Schutte, M.5
-
27
-
-
84876728531
-
Hsp70 protein complexes as drug targets
-
Assimon, V. A.; Gillies, A. T.; Rauch, J. N.; Gestwicki, J. E. Hsp70 protein complexes as drug targets Curr. Pharm. Des. 2013, 19, 404-417
-
(2013)
Curr. Pharm. Des.
, vol.19
, pp. 404-417
-
-
Assimon, V.A.1
Gillies, A.T.2
Rauch, J.N.3
Gestwicki, J.E.4
-
28
-
-
64649094781
-
Solution conformation of wild-type E coli Hsp70 (DnaK) chaperone complexed with ADP and substrate
-
Bertelsen, E. B.; Chang, L.; Gestwicki, J. E.; Zuiderweg, E. R. P. Solution conformation of wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 8471-8476
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 8471-8476
-
-
Bertelsen, E.B.1
Chang, L.2
Gestwicki, J.E.3
Zuiderweg, E.R.P.4
|